De Burlo Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,390
| Closed | -$8.82M | – | 82 |
|
|
2024
Q3 | $8.82M | Sell |
8,390
-300
| -3% | -$315K | 1.09% | 26 |
|
|
2024
Q2 | $9.13M | Buy |
8,690
+600
| +7% | +$631K | 1.23% | 26 |
|
|
2024
Q1 | $7.79M | Buy |
+8,090
| New | +$7.79M | 1.03% | 28 |
|
|
2023
Q2 | – | Sell |
-20,590
| Closed | -$16.9M | – | 91 |
|
|
2023
Q1 | $16.9M | Buy |
20,590
+8,900
| +76% | +$7.31M | 3.3% | 7 |
|
|
2022
Q4 | $8.43M | Hold |
11,690
| – | – | 1.88% | 21 |
|
|
2022
Q3 | $8.05M | Buy |
+11,690
| New | +$8.05M | 1.92% | 18 |
|
|
2022
Q2 | – | Sell |
-26,190
| Closed | -$18.3M | – | 178 |
|
|
2022
Q1 | $18.3M | Buy |
26,190
+13,600
| +108% | +$9.5M | 3.41% | 9 |
|
|
2021
Q4 | $7.95M | Sell |
12,590
-6,610
| -34% | -$4.17M | 1.15% | 31 |
|
|
2021
Q3 | $11.6M | Buy |
+19,200
| New | +$11.6M | 1.88% | 18 |
|
|
2020
Q4 | – | Sell |
-4,750
| Closed | -$2.66M | – | 94 |
|
|
2020
Q3 | $2.66M | Buy |
+4,750
| New | +$2.66M | 0.48% | 46 |
|
|
2019
Q2 | – | Sell |
-18,200
| Closed | -$7.47M | – | 94 |
|
|
2019
Q1 | $7.47M | Buy |
+18,200
| New | +$7.47M | 1.51% | 29 |
|
|
2016
Q1 | – | Sell |
-11,550
| Closed | -$6.27M | – | 100 |
|
|
2015
Q4 | $6.27M | Buy |
11,550
+1,500
| +15% | +$814K | 1.48% | 32 |
|
|
2015
Q3 | $4.67M | Buy |
+10,050
| New | +$4.67M | 1.1% | 44 |
|